• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神疾病与心房颤动患者华法林的使用。

Mental illness and warfarin use in atrial fibrillation.

机构信息

Center for Health Care Evaluation, VA Palo Alto Health Care System, Palo Alto, CA 94025, USA.

出版信息

Am J Manag Care. 2011 Sep;17(9):617-24.

PMID:21902447
Abstract

OBJECTIVES

To determine whether atrial fibrillation (AF) patients with mental health conditions (MHCs) were less likely than AF patients without MHCs to be prescribed warfarin and, if receiving warfarin, to maintain an International Normalized Ratio (INR) within the therapeutic range.

STUDY DESIGN

Detailed chart review of AF patients using a Veterans Health Administration (VHA) facility in 2003.

METHODS

For a random sample of 296 AF patients, records identified clinician-diagnosed MHCs (independent variable) and AF-related care in 2003 (dependent variables), receipt of warfarin, INR values below/above key thresholds, and time spent within the therapeutic range (2.0-3.0) or highly out of range. Differences between the MHC and comparison groups were examined using X2 tests and logistic regression controlling for age and comorbidity.

RESULTS

Among warfarin-eligible AF patients (n = 246), 48.5% of those with MHCs versus 28.9% of those without MHCs were not treated with warfarin (P = .004). Among those receiving warfarin and monitored in VHA, highly supratherapeutic INRs were more common in the MHC group; for example, 27.3% versus 1.6% had any INR >5.0 (P <.001). Differences persisted after adjusting for age and comorbidity.

CONCLUSIONS

MHC patients with AF were less likely than those without MHC to have adequate management of their AF care. Interventions directed at AF patients with MHC may help to optimize their outcomes.

摘要

目的

确定是否伴有心理健康状况(MHC)的房颤(AF)患者比不伴有 MHC 的 AF 患者更不可能被开华法林,如果接受华法林治疗,是否能将国际标准化比值(INR)维持在治疗范围内。

研究设计

2003 年对使用退伍军人健康管理局(VHA)设施的 AF 患者进行详细的图表回顾。

方法

对于 296 名 AF 患者的随机样本,记录确定了临床诊断的 MHC(自变量)和 2003 年与 AF 相关的护理(因变量)、华法林的使用、INR 值低于/高于关键阈值以及在治疗范围内(2.0-3.0)或高度失准范围内花费的时间。使用 X2 检验和逻辑回归控制年龄和合并症来检查 MHC 和对照组之间的差异。

结果

在华法林适用的 AF 患者(n = 246)中,48.5%的 MHC 患者与 28.9%的无 MHC 患者未接受华法林治疗(P =.004)。在接受华法林监测的 VHA 患者中,MHC 组的超高治疗 INR 更为常见;例如,任何 INR >5.0 的患者比例为 27.3%,而 1.6%(P <.001)。调整年龄和合并症后差异仍然存在。

结论

伴有 AF 的 MHC 患者比不伴有 MHC 的患者更不可能得到其 AF 护理的充分管理。针对 MHC 伴有 AF 的患者的干预措施可能有助于改善他们的结局。

相似文献

1
Mental illness and warfarin use in atrial fibrillation.精神疾病与心房颤动患者华法林的使用。
Am J Manag Care. 2011 Sep;17(9):617-24.
2
Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.预测房颤患者在住院环境中使用华法林的因素。
Am J Cardiovasc Drugs. 2010;10(1):37-48. doi: 10.2165/11318870-000000000-00000.
3
Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.老年房颤患者(包括有跌倒和/或早期痴呆症的患者)预防卒中的抗凝治疗:一项单中心、回顾性、观察性研究。
Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.
4
Atrial fibrillation and stroke prevention with warfarin in the long-term care setting.长期护理环境中使用华法林预防心房颤动和中风
Arch Intern Med. 1997 May 12;157(9):978-84.
5
Anticoagulation in atrial fibrillation: impact of mental illness.心房颤动的抗凝治疗:精神疾病的影响
Am J Manag Care. 2015 Nov 1;21(11):e609-17.
6
Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.华法林抗凝强度与急诊就诊患者不良事件风险的关系。
Ann Pharmacother. 2011 Jul;45(7-8):881-7. doi: 10.1345/aph.1P670. Epub 2011 Jul 12.
7
The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation.增加房颤患者出血风险的潜在华法林药物相互作用的性质和频率。
Pharmacoepidemiol Drug Saf. 2002 Oct-Nov;11(7):569-76. doi: 10.1002/pds.748.
8
Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics.心房颤动患者华法林的处方开具:医生、患者及医院特征的影响
Am J Med. 2006 Jul;119(7):607-15. doi: 10.1016/j.amjmed.2005.09.052.
9
Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation.非瓣膜性心房颤动新使用华法林患者的国际标准化比值超出范围与医疗保健费用。
J Med Econ. 2015 May;18(5):333-40. doi: 10.3111/13696998.2014.1001851. Epub 2015 Feb 6.
10
Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.台湾地区心房颤动患者抗血栓药物处方指南的依从性——一项全国性描述性研究
Clin Ther. 2008 Sep;30(9):1726-36. doi: 10.1016/j.clinthera.2008.09.010.

引用本文的文献

1
Selective Serotonin Reuptake Inhibitor Use and Risk of Major Bleeding during Treatment with Vitamin K Antagonists: Results of A Cohort Study.选择性 5-羟色胺再摄取抑制剂的使用与维生素 K 拮抗剂治疗期间大出血风险的相关性:一项队列研究的结果。
Thromb Haemost. 2023 Feb;123(2):245-254. doi: 10.1055/a-1957-6305. Epub 2022 Oct 8.
2
Impact of social determinants of health on anticoagulant use among patients with atrial fibrillation: Systemic review and meta-analysis.社会决定因素对心房颤动患者抗凝治疗的影响:系统评价和荟萃分析。
Medicine (Baltimore). 2022 Sep 2;101(35):e29997. doi: 10.1097/MD.0000000000029997.
3
Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.
精神分裂症合并心房颤动患者口服抗凝剂起始的差异:一项全国性队列研究。
Br J Clin Pharmacol. 2022 Aug;88(8):3847-3855. doi: 10.1111/bcp.15337. Epub 2022 Apr 8.
4
Evaluation of Warfarin Use in Patients With Mental Health Conditions in a Rural Community Health Center System.农村社区卫生中心系统中患有精神健康疾病患者华法林使用情况的评估。
J Pharm Technol. 2021 Feb;37(1):17-22. doi: 10.1177/8755122520960226. Epub 2020 Oct 14.
5
The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study.心理健康状况对心房颤动患者使用口服抗凝治疗的影响:FinACAF 研究。
Eur Heart J Qual Care Clin Outcomes. 2022 May 5;8(3):269-276. doi: 10.1093/ehjqcco/qcab077.
6
The impact of mental health conditions on oral anticoagulation therapy and outcomes in patients with atrial fibrillation: A systematic review and meta-analysis.心理健康状况对心房颤动患者口服抗凝治疗及预后的影响:一项系统评价和荟萃分析。
Am J Prev Cardiol. 2021 Jun 27;7:100221. doi: 10.1016/j.ajpc.2021.100221. eCollection 2021 Sep.
7
Association Between Bipolar Disorder or Schizophrenia and Oral Anticoagulation Use in Danish Adults With Incident or Prevalent Atrial Fibrillation.丹麦新发或现患心房颤动成人中双相情感障碍或精神分裂症与口服抗凝药物使用的相关性。
JAMA Netw Open. 2021 May 3;4(5):e2110096. doi: 10.1001/jamanetworkopen.2021.10096.
8
The unmeasured burden: Contribution of depression and psychological stress to patient-reported outcomes in atrial fibrillation.未被测量的负担:抑郁和心理压力对心房颤动患者报告结局的贡献。
Int J Cardiol. 2020 Mar 1;302:75-80. doi: 10.1016/j.ijcard.2019.12.004. Epub 2019 Dec 5.
9
Using the Symmetry Analysis Design to Screen for Adverse Effects of Non-vitamin K Antagonist Oral Anticoagulants.利用对称性分析设计筛选非维生素 K 拮抗剂口服抗凝剂的不良反应。
Drug Saf. 2018 Jul;41(7):685-695. doi: 10.1007/s40264-018-0650-6.
10
Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study.重度精神障碍患者的心房颤动与中风、致命性血栓栓塞事件及出血风险:一项全国性队列研究
BMJ Open. 2017 Dec 6;7(12):e018209. doi: 10.1136/bmjopen-2017-018209.